Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danggui Liuhuang Granules is a Traditional Chinese Medicine (TCM) formulation developed by Shandong Hongjitang Pharmaceutical. It is a modernized granule version of the classic TCM formula "Danggui Liuhuang Tang," which traditionally consists of seven herbal ingredients: *Radix Angelicae Sinensis* (Danggui), *Radix Rehmanniae* (Shengdi), *Radix Rehmanniae Praeparata* (Shudi), *Rhizoma Coptidis* (Huanglian), *Radix Scutellariae* (Huangqin), *Cortex Phellodendri* (Huangbai), and *Radix Astragali* (Huangqi). The formula is traditionally indicated for the treatment of Yin deficiency with internal heat, specifically targeting symptoms such as night sweats (hyperhidrosis), feverish sensations, and dry mouth. Shandong Hongjitang is currently engaged in the secondary development of this established drug, focusing on optimizing the preparation into a granule form to improve stability, standardization, and patient convenience.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on danggui liuhuang granules.